Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Similar articles for PubMed (Select 22113009)

1.

Interactions between hepatitis B virus and aflatoxin B(1): effects on p53 induction in HepaRG cells.

Lereau M, Gouas D, Villar S, Besaratinia A, Hautefeuille A, Berthillon P, Martel-Planche G, Nogueira da Costa A, Ortiz-Cuaran S, Hantz O, Pfeifer GP, Hainaut P, Chemin I.

J Gen Virol. 2012 Mar;93(Pt 3):640-50. doi: 10.1099/vir.0.032482-0. Epub 2011 Nov 23.

2.

p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.

Lunn RM, Zhang YJ, Wang LY, Chen CJ, Lee PH, Lee CS, Tsai WY, Santella RM.

Cancer Res. 1997 Aug 15;57(16):3471-7.

3.

TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.

Hussain SP, Schwank J, Staib F, Wang XW, Harris CC.

Oncogene. 2007 Apr 2;26(15):2166-76. Review.

PMID:
17401425
4.

Interaction of aflatoxin and hepatitis B virus in the pathogenesis of hepatocellular carcinoma.

Rajagopalan MS, Busch MP, Blum HE, Vyas GN.

Life Sci. 1986 Oct 6;39(14):1287-90.

PMID:
3020328
5.

A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses.

Moudgil V, Redhu D, Dhanda S, Singh J.

J Environ Pathol Toxicol Oncol. 2013;32(2):165-75. Review.

PMID:
24099430
6.
7.
8.

Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.

Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA.

Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):617-25.

9.

Seasonal variation in TP53 R249S-mutated serum DNA with aflatoxin exposure and hepatitis B virus infection.

Villar S, Le Roux-Goglin E, Gouas DA, Plymoth A, Ferro G, Boniol M, Lereau M, Bah E, Hall AJ, Wild CP, Mendy M, Norder H, van der Sande M, Whittle H, Friesen MD, Groopman JD, Hainaut P.

Environ Health Perspect. 2011 Nov;119(11):1635-40. doi: 10.1289/ehp.1103539. Epub 2011 Jul 18.

10.

Chronic hepatitis B virus infection in Asian countries.

Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, Hasnian SS, Leung N, Lesmana L, Phiet PH, Sjalfoellah Noer HM, Sollano J, Sun HS, Xu DZ.

J Gastroenterol Hepatol. 2000 Dec;15(12):1356-61. Review.

PMID:
11197043
11.

Oltipraz, a novel inhibitor of hepatitis B virus transcription through elevation of p53 protein.

Chi WJ, Doong SL, Lin-Shiau SY, Boone CW, Kelloff GJ, Lin JK.

Carcinogenesis. 1998 Dec;19(12):2133-8.

12.

Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.

Kim HJ, Yoo HS, Kim JC, Park CS, Choi MS, Kim M, Choi H, Min JS, Kim YS, Yoon SW, Ahn JK.

J Ethnopharmacol. 2009 Jul 15;124(2):189-96. doi: 10.1016/j.jep.2009.04.046. Epub 2009 May 3.

PMID:
19409970
13.

Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.

Vincent IE, Lucifora J, Durantel D, Hantz O, Chemin I, Zoulim F, Trepo C.

Antivir Ther. 2009;14(1):131-5.

PMID:
19320247
14.

Ataxia telangiectasia-mutated-Rad3-related DNA damage checkpoint signaling pathway triggered by hepatitis B virus infection.

Zhao F, Hou NB, Yang XL, He X, Liu Y, Zhang YH, Wei CW, Song T, Li L, Ma QJ, Zhong H.

World J Gastroenterol. 2008 Oct 28;14(40):6163-70.

15.

Hepatocyte polarization is essential for the productive entry of the hepatitis B virus.

Schulze A, Mills K, Weiss TS, Urban S.

Hepatology. 2012 Feb;55(2):373-83. doi: 10.1002/hep.24707. Epub 2011 Dec 16.

PMID:
21953491
16.

Mutations of p53 gene in hepatocellular carcinoma: roles of hepatitis B virus and aflatoxin contamination in the diet.

Hsia CC, Kleiner DE Jr, Axiotis CA, Di Bisceglie A, Nomura AM, Stemmermann GN, Tabor E.

J Natl Cancer Inst. 1992 Nov 4;84(21):1638-41.

PMID:
1279184
17.

Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.

Gouas DA, Shi H, Hautefeuille AH, Ortiz-Cuaran SL, Legros PC, Szymanska KJ, Galy O, Egevad LA, Abedi-Ardekani B, Wiman KG, Hantz O, Caron de Fromentel C, Chemin IA, Hainaut PL.

Carcinogenesis. 2010 Aug;31(8):1475-82. doi: 10.1093/carcin/bgq118. Epub 2010 Jun 10.

18.
19.

Association of aflatoxin B(1)-albumin adduct levels with hepatitis B surface antigen status among adolescents in Taiwan.

Chen SY, Chen CJ, Chou SR, Hsieh LL, Wang LY, Tsai WY, Ahsan H, Santella RM.

Cancer Epidemiol Biomarkers Prev. 2001 Nov;10(11):1223-6.

20.

Control of hepatitis B virus replication by innate response of HepaRG cells.

Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F.

Hepatology. 2010 Jan;51(1):63-72. doi: 10.1002/hep.23230.

PMID:
19877170
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk